Eric Warren - 17 May 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Commercial Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
17 May 2022
Transactions value $
-$1,172
Form type
4
Filing time
18 May 2022, 16:30:00 UTC
Previous filing
16 Mar 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$1.17K -196 -0.36% $5.98* 53.9K 17 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.